Drug Profile
Research programme: antifungals - Merck & Co
Alternative Names: Ilicicolin HLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Benzaldehydes
- Mechanism of Action NADH and NADPH oxidoreductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Mycoses in USA
- 12 Sep 2012 Preclinical trials in Mycoses in USA (unspecified route)
- 12 Sep 2012 Pharmacodynamics data from a Preclinical trial in Mycoses presented at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2012)